A practical reference on Stenabolic: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2025-08-17 and is reviewed periodically as new material appears.
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
Stability depends on physical form, temperature, light exposure, and solvent. Solid SR9009 is generally stored cold and dry, with protection from light to limit degradation. Dimethyl sulfoxide stocks are common for laboratory work, but repeated freeze-thaw cycles can reduce compound integrity. Aqueous solutions may be less stable than organic stocks, and the ethyl ester in the structure can be susceptible to hydrolysis under certain conditions. Researchers typically validate storage conditions and recheck purity before quantitative experiments, especially when using archived material.
Regulatory treatment of SR9009 varies by country and region. It is not approved as a pharmaceutical, and several jurisdictions restrict its sale for human consumption. Some authorities classify it as a research chemical, a prescription-only substance, or a prohibited performance-enhancing agent in sport. Purchasers may encounter certificates of analysis, but these documents do not guarantee identity, purity, or legality. In research settings, institutional safety reviews and controlled procurement help ensure that materials are handled under appropriate oversight. The absence of harmonized rules means that legal status can change and requires verification.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human use | Research-use-only status in many markets |
| WADA status | Prohibited in sport | Generally listed as a non-approved substance |
| Detection technique | LC-MS/MS | Common for urine and blood analysis |
| Common alias | Stenabolic | Informal market nickname, not a pharmacopoeial name |
| Purity check | HPLC or LC-UV | Independent certificate of analysis is typical |
SR9009 is a synthetic small molecule that acts on the nuclear receptors REV-ERBα and REV-ERBβ. These receptors are part of the circadian clock machinery and normally repress transcription of certain target genes. In laboratory research, SR9009 is used as a chemical tool to study how REV-ERB activity influences metabolism, inflammation, and daily biological rhythms. The compound is not an approved medicine, and its effects in humans remain largely uncharacterized. It is often described as an investigational agent rather than a therapeutic product.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
==== Pilosan research ==== Casali et al. (2026) identify a poorly developed dental alveolus in a specimen of Nothrotherium maquinense from the Pleistocene strata from Brazil, occupying the position of caniniform alveolus in Neogene nothrotheriids, and interpreted as a possible case of partial re-expression of a lost ancestral dental condition in the studied individual. Revision of nematheriine scelidotheriid sloths from the Miocene Santa Cruz Formation (Argentina) is published by Boscaini et al. (2026), who assign all studied fossils to the genus Nematherium, with the majority of them assigned to the species N. angulatum New fossil material of Ocnotherium giganteum, including a nearly complete skull and two partial skeletons, is described from the Pleistocene strata from Brazil by Pujos et al. (2026), who recover O. giganteum as a mylodontine mylodontid. Evidence from the study of a mylodontid coprolite from the Pleistocene strata from the Cueva Cacao 1.A site (Argentina) indicative of a grazing-browsing dietary niche of the producer is presented by Velázquez et al. (2026). Zicos et al. (2026) compare the utility of three ancient DNA extraction methods for recovery of DNA from coprolites of Mylodon darwinii and soil samples from Cueva del Milodón (Chile), and report recovery of both sloth mitochondrial genomes and signatures of local flora. Harper et al.
== Diagnosis == Perichondral hematoma and consequently cauliflower ear are diagnosed clinically. This means that the medical provider will make the diagnosis by using elements of the history of the injury (examples: participation in contact sports, trauma to the ear, previous similar episodes) and combine this with findings on physical exam (examples: tenderness to the area, bruising, deformation of the ear contours) to confirm the diagnosis and decide on the appropriate treatment for the patient.
is able to account for the decrease in viscosity observed in some solutions. Estimated values of these constants are shown below for sodium chloride and potassium iodide at temperature 25 °C (mol = mole, L = liter).
== Regulation of muscle protein synthesis == Early experiments on rat diaphragm muscle demonstrated that a mixture of BCAAs alone stimulated muscle growth to a similar extent as a complete amino acid mixture. By contrast, an amino acid mixture lacking BCAAs had no effect on muscle growth. Among the three BCAAs, administration of leucine alone produced nearly the same effect as the full BCAA mixture, whereas isoleucine or valine alone had little impact. Leucine promotes protein synthesis through indirect activation of p70 S6 kinase and stimulation of assembly of the eIF4F complex, both of which are essential for initiation of mRNA translation. P70 S6 kinase is a downstream component of the mammalian target of rapamycin complex (mTOR) pathway, which regulates adaptive hypertrophy and recovery in skeletal muscle. At rest, infusion of protein stimulates muscle protein synthesis within 30 minutes, with elevated rates persisting for approximately 90 minutes. Leucine infusion at rest produces a prolonged stimulatory effect, maintaining increased protein synthesis for up to six hours through phosphorylation of p70 S6 kinase in skeletal muscle. Following resistance exercise without BCAA administration, phosphorylation of mTOR is not significantly increased, and phosphorylation of Akt may even decline, although some activation of p70 S6 kinase is observed. In contrast, post-exercise BCAA supplementation induces robust phosphorylation of p70 S6 kinase and its downstream target S6, consistent with activation of the mTOR signaling cascade.
Sources: en.wikipedia.org
Before the establishment of the State of Israel in 1948, the Druze lived in the Galilee and Mount Carmel, either in exclusively Druze villages or in villages mixed with Christians, where they had coexisted for centuries. Historically, the relationship between the Druze and their Christian neighbors was better compared to their relationship with their Muslim neighbors in neighboring villages. According to historian Ilan Pappé, during the 1948 Arab–Israeli War, in villages partly inhabited by Druze, Christians were generally exempt from expulsion. According to Pappé, in 1948, Israeli military rulers gathered Christians in the centers of several villages in the Galilee region, planning to deport them. However, Druze village leaders intervened, insisting that all Christians remain in their homes. They utilized all their influence and resources to ensure that the Christian residents could stay. The Galilean village of Rameh, with a Christian majority, was not displaced because of its large Druze population. While the "divide and rule" policy succeeded with the Druze, who were promised immunity, weapons, and privileges, by the Zionist militias, the Palestinian Christian communities were less "cooperative". Israeli Druze and Muslims have comparable socio-economic standards when compared to their wealthier and more educated Israeli Christian counterparts.
Cell signaling is the process by which a cell interacts with itself, other cells, and the environment. Typically, the signaling process involves three components: the first messenger (the ligand), the receptor, and the signal itself. Most cell signaling is chemical in nature, and can occur with neighboring cells or more distant targets. Signal receptors are complex proteins or tightly bound multimer of proteins, located in the plasma membrane or within the interior. Each cell is programmed to respond to specific extracellular signal molecules, and this process is the basis of development, tissue repair, immunity, and homeostasis. Individual cells are able to manage receptor sensitivity including turning them off, and receptors can become less sensitive when they are occupied for long durations. Errors in signaling interactions may cause diseases such as cancer, autoimmunity, and diabetes.
=== Biscuits company === In 1938, Lyons purchased the Bee Bee Biscuit Company, which manufactured biscuits from its factories in Blackpool. Six years later, Lyons changed the company's name to Symbol Biscuits Ltd. and began selling biscuits under the Symbol and Lyons brand names: one of their innovations was Maryland Cookies in 1956. In 1990, Lyons changed the Symbol Biscuits name to Lyons Biscuits Ltd.
Sources: en.wikipedia.org
The two substrates of this enzyme are D-sorbitol 6-phosphate and oxidised nicotinamide adenine dinucleotide (NAD+). Its products are fructose 6-phosphate (shown in its open-chain form), reduced NADH, and a proton. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-OH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is D-sorbitol-6-phosphate:NAD+ 2-oxidoreductase. Other names in common use include ketosephosphate reductase, ketosephosphate reductase, D-sorbitol 6-phosphate dehydrogenase, D-sorbitol-6-phosphate dehydrogenase, sorbitol-6-P-dehydrogenase, and D-glucitol-6-phosphate dehydrogenase. This enzyme participates in fructose and mannose metabolism.
== Structure == Although engineered and modified in a laboratory setting, ELPs share structural characteristics with intrinsically disordered proteins (IDPs) naturally found in the body, such as tropoelastin, from which ELPs were given their name. The repeat sequences found in the biopolymer give each ELP a distinct structure, as well as influence the lower critical solution temperature (LCST), also referred to commonly as the Tt. It is at this temperature that the ELPs move from a linear, relatively disordered state to a more densely aggregated, partially ordered state Although given as a single temperature, Tt, the ELP phase change process generally begins and ends within a temperature range of approximately 2 °C. Also, Tt is altered by the addition of unique proteins to the free ELPs.
pH (rate increases with increasing pH ( 6–8.5)), presence of halide ions (cause Ag+ precipitation), particle coating presence of reducing sugars. The presence of cysteine (inhibits dissolution). presence of natural organic matter.
Sources: en.wikipedia.org
Legality depends on the country and the intended use. In many places it is not approved as a medicine and may be sold only as a research chemical. Importation or possession can be restricted, and sports organizations prohibit it.
Anti-doping laboratories typically use LC-MS/MS to detect SR9009 or its metabolites in urine or blood. The exact assay depends on the laboratory and the testing program. Detection can be challenging because the compound may be rapidly metabolized and present at low levels.
Stenabolic is an informal nickname used in online fitness and research-chemical markets, not an official drug name. It likely references reported effects on endurance in rodent studies. The nickname does not imply approval or proven human benefit.
The most common approach is liquid chromatography-tandem mass spectrometry, often after extraction from blood, urine, or tissue. Ultraviolet detection and nuclear magnetic resonance spectroscopy are used mainly for reference material characterization. Isotope-labeled internal standards improve accuracy.